Executive Decision Making for Pharma & Biotech Participant Testimonials
2023
“Excellent sessions focused on "doing" portfolio management-- experienced, thought-provoking speakers with interesting perspectives and great networking.”
Leslie Lippard, Senior Director, Portfolio Analytics, Alnylam
“This is an informative meeting with many good networking opportunities.”
May Zhu, Director, Takeda Pharmaceuticals
“Great forum to learn from portfolio management thought leaders from across the pharma industry.”
Carlos Nunes, Vice President of Portfolio Analytics, i2e Consulting
“Excellent topics with thought provoking discussions.”
Francine Safir, Director, Project Management Office, Taiho Oncology Inc
2022
"This conference attracted a great set of attendees from companies and from vendors-- the best that I have ever attended. As such, it was a great opportunity to learn from others and to catch up on broad trends. My perspective shifted from being focused 1-3 years out to really thinking about the longer term, and how to get my company from where we are today to where we need to be in the long term."
Biopharma Portfolio Manager, 2022 Attendee
“I think the event was really valuable and it was great to make some connections across the industry. I loved the casual/friendly vibe of the conference and openness of the conversations between peers.”
Brigitte Healion, Associate Director Solutions Designer, Janssen Pharmaceuticals (Johnson & Johnson)
“The Resource Management community within pharma is such a small group of people that it is always wonderful when we can get together, learn, share, and return to our companies energized. No one in our respective organizations knows as much about our discipline as these peers, so this time sharing best practices is beyond valuable. I’ve attended this conference at least five times over the past ten years and have always come away with great nuggets to help me sharpen the saw in my role.”
Michael Ferrante, GRACS Business Analytics, Merck
“The meeting was great and had a really good blend of brief talks broken up with panel discussions – in the room and in the breakout room that really allowed for more sharing of issues and best practices. The meeting enrolled a number of really top experts in their field – we heard growth stories and stories of retraction/refocusing which is the ultimate reality for companies in our business. Overall, I found it to be a great forum for benchmarking.”
Michael Myers, Associate Vice President, Eli Lilly & Co
Prior Years
"Meetings like these are very helpful for advancing the collective productivity of the industry, and in so doing, help everyone by enabling and expediting the development of new medicines for the patients that need them."
Vice President, WRD Business Operations, Pfizer, Inc.
"This was a great event, and I am looking forward to next year! I like the size of the conference which really allows for participants to interact, exchange ideas and collaborate. Also, it was possible for everyone to ask questions at the end of every presentation."
Captario
"I really liked the open discussion and small meeting format. I thought the engagement by those attendees in the room was insightful and I learned from the group."
Attendee